Anna Maria Storniolo

  • 11919 Citations
  • 38 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibility

Mosher, C. E., Tometich, D. B., Hirsh, A., Rand, K. L., Johns, S. A., Matthias, M. S., Outcalt, S., Bricker, J., Schneider, B., Mina, L., Storniolo, A. M., Newton, E. & Miller, K., Nov 2017, In : Psycho-Oncology. 26, 11, p. 1944-1951 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Synthesis and Biological Activity of 2′,2′-Difluorodeoxycytidine (Gemcitabine)

Hertel, L. W., Kroin, J. S., Grossman, C. S., Grindey, G. B., Dorr, A. F., Storniolo, A. M. V., Plunkett, W., Gandhi, V. & Huang, P., Dec 1 1996, In : ACS Symposium Series. 639, p. 265-278 14 p.

Research output: Contribution to journalArticle

15 Scopus citations

TBCRC 001: Randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer

Carey, L. A., Rugo, H. S., Marcom, P. K., Mayer, E. L., Esteva, F. J., Ma, C. X., Liu, M. C., Storniolo, A. M., Rimawi, M. F., Forero-Torres, A., Wolff, A. C., Hobday, T. J., Ivanova, A., Chiu, W. K., Ferraro, M., Burrows, E., Bernard, P. S., Hoadley, K. A., Perou, C. M. & Winer, E. P., Jul 20 2012, In : Journal of Clinical Oncology. 30, 21, p. 2615-2623 9 p.

Research output: Contribution to journalArticle

296 Scopus citations

TBCRC 002: A phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

Vaklavas, C., Roberts, B. S., Varley, K. E., Lin, N. U., Liu, M. C., Rugo, H. S., Puhalla, S., Nanda, R., Storniolo, A. M., Carey, L. A., Saleh, M. N., Li, Y., Delossantos, J. F., Grizzle, W. E., Lobuglio, A. F., Myers, R. M. & Forero-Torres, A., Feb 18 2020, In : Breast Cancer Research. 22, 1, 22.

Research output: Contribution to journalArticle

Open Access

TBCRC 008: Early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer

Connolly, R. M., Leal, J. P., Goetz, M. P., Zhang, Z., Zhou, X. C., Jacobs, L. K., Mhlanga, J., Joo, H. O., Carpenter, J., Storniolo, A. M., Watkins, S., Fetting, J. H., Miller, R. S., Sideras, K., Jeter, S. C., Walsh, B., Powers, P., Zorzi, J., Boughey, J. C., Davidson, N. E. & 6 others, Carey, L. A., Wolff, A. C., Khouri, N., Gabrielson, E., Wahl, R. L. & Stearns, V., Jan 1 2015, In : Journal of Nuclear Medicine. 56, 1, p. 31-37 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

TBCRC 018: Phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

Anders, C., Deal, A. M., Abramson, V., Liu, M. C., Storniolo, A. M., Carpenter, J. T., Puhalla, S., Nanda, R., Melhem-Bertrandt, A., Lin, N. U., Kelly Marcom, P., Van Poznak, C., Stearns, V., Melisko, M., Smith, J. K., Karginova, O., Parker, J., Berg, J., Winer, E. P., Peterman, A. & 4 others, Prat, A., Perou, C. M., Wolff, A. C. & Carey, L. A., Aug 2014, In : Breast Cancer Research and Treatment. 146, 3, p. 557-566 10 p.

Research output: Contribution to journalArticle

26 Scopus citations

TBCRC 019: A phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple-negative breast cancer

Translational Breast Cancer Research Consortium (TBCRC), Jun 15 2015, In : Clinical Cancer Research. 21, 12, p. 2722-2729 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

TBCRC023: A randomized phase II neoadjuvant trial of lapatinib plus trastuzumab without chemotherapy for 12 versus 24 weeks in patients with HER2-positive breast cancer

on behalf of the Translational Breast Cancer Research Consortium, Feb 15 2020, In : Clinical Cancer Research. 26, 4, p. 821-827 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

TBCRC026: Phase II trial correlating standardized uptake value with pathologic complete response to pertuzumab and trastuzumab in breast cancer

Connolly, R. M., Leal, J. P., Solnes, L., Huang, C. Y., Carpenter, A., Gaffney, K., Abramson, V., Carey, L. A., Liu, M. C., Rimawi, M., Specht, J., Storniolo, A. M., Valero, V., Vaklavas, C., Krop, I. E., Winer, E. P., Camp, M., Miller, R. S., Wolff, A. C., Cimino-Mathews, A. & 3 others, Park, B. H., Wahl, R. L. & Stearns, V., Mar 20 2019, In : Journal of Clinical Oncology. 37, 9, p. 714-722 9 p.

Research output: Contribution to journalArticle

9 Scopus citations

Terminal duct lobular unit involution of the normal breast: Implications for breast cancer etiology

Figueroa, J. D., Pfeiffer, R. M., Patel, D. A., Linville, L., Brinton, L. A., Gierach, G. L., Yang, X. R., Papathomas, D., Visscher, D., Mies, C., Degnim, A. C., Anderson, W. F., Hewitt, S., Khodr, Z. G., Clare, S. E., Storniolo, A. M. & Sherman, M. E., Oct 1 2014, In : Journal of the National Cancer Institute. 106, 10, dju286.

Research output: Contribution to journalArticle

39 Scopus citations

The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: A unique resource for defining the "molecular histology" of the breast

Sherman, M. E., Figueroa, J. D., Henry, J. E., Clare, S. E., Rufenbarger, C. & Storniolo, A. M., Apr 1 2012, In : Cancer Prevention Research. 5, 4, p. 528-535 8 p.

Research output: Contribution to journalComment/debate

27 Scopus citations

Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast Cancer

Wu, W., Wagner, E. K., Hao, Y., Rao, X., Dai, H., Han, J., Chen, J., Storniolo, A. M. V., Liu, Y. & He, C., Sep 6 2016, In : Scientific reports. 6, 32731.

Research output: Contribution to journalArticle

15 Scopus citations

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008

Connolly, R. M., Fackler, M. J., Zhang, Z., Zhou, X. C., Goetz, M. P., Boughey, J. C., Walsh, B., Carpenter, J. T., Storniolo, A. M., Watkins, S. P., Gabrielson, E. W., Stearns, V. & Sukumar, S., Jan 1 2018, In : Breast Cancer Research and Treatment. 167, 1, p. 107-116 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients

Hertz, D. L., Speth, K. A., Kidwell, K. M., Gersch, C. L., Desta, Z., Storniolo, A. M., Stearns, V., Skaar, T. C., Hayes, D. F., Henry, N. L. & Rae, J. M., Oct 1 2017, In : Breast Cancer Research and Treatment. 165, 3, p. 659-668 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes

Philips, S., Rae, J. M., Oesterreich, S., Hayes, D. F., Stearns, V., Henry, N. L., Storniolo, A. M., Flockhart, D. A. & Skaar, T. C., Sep 13 2012, In : Frontiers in Pharmacology. 3 MAR, 54.

Research output: Contribution to journalArticle

1 Scopus citations